TARS2 and cholelithiasis: Methylation of cg09579323 in TARS2 (OR = 1.05, 95% CI = 1.02–1.08) was associated with an increased risk of cholelithiasis, whereas increased TARS2 gene expression (OR = 0.73, 95% CI = 0.62–0.86) was associated with a reduced cholelithiasis risk.